期刊文献+

α-葎草烯调控NRG1/ErbB4信号通路改善精神分裂症研究 被引量:7

α-humulene improves schizophrenia via NRG1/ErbB4 signaling pathway
原文传递
导出
摘要 目的探讨α-葎草烯对小鼠精神分裂症的作用机制。方法采用地卓西平马来酸盐(MK801)建立精神分裂症小鼠模型,用不同浓度α-葎草烯进行ig给药。对各组小鼠进行旷场试验和前脉冲抑制(PPI)测试,评估小鼠自发活动量和感觉运动门控功能;检测小鼠额前脑组织NO活性、MDA含量;Westernblotting法检测小鼠海马组织NRG1、ErbB4蛋白表达水平。结果与对照组比较,模型组小鼠的活动量明显增加,PPI受损(P<0.01);脑内NO活性、MDA含量、NRG1、ErbB4蛋白表达显著增加(P<0.01)。与模型组比较,不同浓度α-葎草烯组中小鼠活动量明显降低,PPI异常明显改善,NO和MDA含量、NRG1和ErbB4蛋白表达均明显降低(P<0.05、0.01)。结论α-葎草烯通过下调NRG1/ErbB4信号通路,改善精神分裂症小鼠异常行为,从而达到治疗精神分裂症的目的。 Objective To study the treating mechanism ofα-humulene on the schizophrenic mice.Methods The schizophrenic models were established by dizocilpine maleate(MK801),then different concentrations ofα-humulene were used to treat the mice by intragastric administration.Open-field experiment and PPI test were carried out to evaluate the spontaneous activity and sensorimotor gating function of mice.Moreover,the frontal cortex MDA,NO levels and hippocampal NRG1,ErbB4 protein expression was detected.Results The spontaneous activity,sensorimotor gating function,MDA,NO,NRG1 and ErbB4 levels were significantly changed in model mice when compared with normal mice(P<0.01).Compared with model group,different concentrations ofα-humulene notably inhibited spontaneous activity,improved PPI value,increased NO and MDA content,down-regulated ErbB4 and NRG1 protein expression(P<0.05,P<0.01).Conclusion The schizophrenia abnormal behavior of mice was improved byα-humulene via down-regulating NRG1/ErbB4 signaling pathway,so as to achieve the purpose of treating schizophrenia.
作者 陈杰 陈策 刘立滢 戴伯坚 金晓庄 汤锦磊 邓江南 CHEN Jie;CHEN Ce;LIU Li-ying;DAI Bo-jian;JIN Xiao-zhuang;TANG Jin-lei;DENG Jiang-nan(Wenzhou Municipal 7th People’s Hospital,Wenzhou 325000,China)
出处 《中草药》 CAS CSCD 北大核心 2019年第23期5790-5794,共5页 Chinese Traditional and Herbal Drugs
关键词 葎草烯 地卓西平马来酸盐(MK801) 精神分裂症 NRG1/ErbB4信号通路 NO α-humulene dizocilpine maleate(MK801) schizophrenia NRG1/ErbB4 signaling pathway NO
  • 相关文献

参考文献8

二级参考文献114

  • 1黄继忠,王祖承.精神分裂症病因学研究的新热点:NMDA机能低下假说[J].上海精神医学,2003,15(3):176-178. 被引量:1
  • 2苏晶,郝丽莉.精神分裂症的中医药研究及展望[J].中医药信息,1994,11(5):5-7. 被引量:3
  • 3马学毅 郭峰 等.贵阳石草蒲精油化学成分的研究[J].色谱,1993,11(6):336-338.
  • 4向仁德 姚志成.石菖蒲挥发油化学成分的研究[J].中药通报,1983,8:31-32,27.
  • 5中国医学科学院药物研究所药理室.石菖蒲药理作用的初步研究[J].新医学,1977,(6):46-48.
  • 6沈渔邨.精神病学[M].北京:人民卫生出版社,2009.251.
  • 7Manahan-Vaughan D, Wildforster V, Thomsen C, et al. Rescue of hippocampal LTP and learning deficits in a rat model of psychosis by inhibition of glycine transporter-1 (GlyT1)[J]. Eur J Neurosci,2008,28 (7) : 1342-1350.
  • 8Shiigi Y, Casey DE. Behavioral effects of ketamine, an NMDA glutamatergic antagonist, in non-human primates [J]. Psychopharmacology (Berl), 1999,146 ( 1 ) : 67-72.
  • 9Becker A, Grecksch G. Ketamine-induced changes in rat behaviour: a possible animal model of schizophrenia. Test of predictive validity[J]. Prog Neuropsychopharmacol Biol Psychiatry,2004,28(8):1267-1277.
  • 10Gunduz-Bruce H. The acute effects of NMDA antagonism: from the rodent to the human brain[J]. Brain Res Rev, 2009,60 (2) : 279-286.

共引文献98

同被引文献153

引证文献7

二级引证文献40

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部